• US Stocks
  • Sanofi


Large Cap 
  • $ 48.79

    Stock Price

  • $ 0.23(0.47%)

    Last Change

About the company


Sanofi researches, develops, manufactures, and markets therapeutic solutions. The company operates in two segments, Pharmaceuticals and Vaccines. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an oral immunomodulatory and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for various cancers; Eloxatin, a platinum agent for colorectal cancer; Thymoglobulin, a immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer for hematologic malignancies; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Lantus, Apidra, and Insuman human insulins; Toujeo, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; and Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; and Praluent, a cholesterol-lowering drug and Multaq, an anti-arrhythmic drug to treat cardiovascular diseases. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and treatment of venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for patients with osteoarthritis; Stilnox for treatment of insomnia; and Allegra, an anti-histamine for the treatment of seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
View More
    Total Revenue
    Cost of Revenue
    Gross Profit
    Operating Income
Scripbox Recommended US Equity Funds
Want to get exposure to US Equity with the ease of Mutual Funds?Learn more

Price chart

$ 49.36

1D High

$ 0.00

1D Low

$ 0.23 (0.47%)

1D Change

Last updated on 

Previous Close
$ 48.56
Open Price
$ 48.88
52 Week High
$ 56.20
52 Week Low
$ 36.91
PE Ratio
Avg. Volume
Market Cap
$ 123.032 B


Stock NameStock Price52 Week High52 Week LowCapital
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
$ 8.63$ 11.45$ 7.09Mid Cap
$ 94.04$ 105.61$ 78.81Large Cap
$ 98.46$ 122.66$ 92.83Large Cap
$ 155.56$ 181.77$ 151.23Large Cap
$ 56.28$ 78.63$ 55.70Large Cap
$ 769.34$ 794.47$ 306.63Large Cap
$ 103.35$ 118.05$ 94.42Large Cap
$ 144.76$ 145.94$ 95.02Large Cap
$ 32.34$ 53.25$ 31.77Large Cap
$ 42.16$ 42.24$ 31.91Large Cap

Frequently Asked Questions

What is the price of Sanofi share today in India?

Today, on 23rd Feb 2024, the price of Sanofi Shares in India is $ 48.79.

What was the highest Sanofi share stock price?

The highest Sanofi stock price was $ 56.2 till 23rd Feb 2024 within the past 52 weeks.

What is the lowest price of SNY shares?

The lowest SNY stock price was $ 36.91 on 23rd Feb 2024 within the past 52 weeks.

How to buy SNY shares in India?

You can buy SNY shares in India through Scripbox in just 4 simple steps. The process is simple, seamless, and paperless.
  • Create an account and submit KYC documents
  • On successful KYC, transfer amount required for investment
  • Invest in US stocks
  • Track and manage investments through Scripbox dashboard

Is Sanofi shares Listed on NSE or BSE?

No, SNY shares are not listed on NSE or BSE. Sanofi is listed on the NASDAQ stock exchange.

Can I buy Sanofi shares in India?

Yes, you can buy Sanofi shares in India by simply opening an account with Scripbox.

Can I buy fractional shares of Sanofi?

Yes, you can buy fractional shares of Sanofi with Scripbox.

What is the P/E ratio for Sanofi shares?

As on 23rd Feb 2024, the P/E ratio for Sanofi shares is 13.67.

What is the traded volume of Sanofi shares?

As on 23rd Feb 2024, the traded volume for Sanofi shares is 955.630 undefined.

What is the market capitalization of Sanofi shares?

Sanofi shares has a market capitalization of $ 123.032 B.